Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01806779 · ClinicalTrials.gov registry record · Phase 2
Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 376
- Enrollment target
NCT01806779: Completed Phase 2 study, sponsored by Duke University.
NCT01806779 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 376 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (183% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01806779, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 376 participants
- Enrollment target
Study Summary
Previous results from the investigators' Center have shown that combination treatment with Chantix and Zyban is more successful in helping men quit smoking. The investigators hope to replicate these findings with this study.
Primary Outcome
This will be determined by a composite of self-report at the 11-week study visit of no smoking between the 8-week and 11-week visits and expired air carbon monoxide (CO) \<10 ppm (measured at the 11-week study visit). An intent-to-treat criterion will be used, whereby drop-outs are considered to be non-abstinent.
Interventions
- DRUG Zyban
- DRUG Chantix
- DRUG Nicotine patches
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 376 participants |
| Start Date | 2013-03 |
| Est. Completion | 2015-03 |
| Phase | Phase 2 |
What the finished NCT01806779 record still lists
NCT01806779 is an interventional study that assigns participants to a tested intervention. The registered 376 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (183% higher).
The record links to 0 conditions, and to 3 interventions - of which Zyban is the first listed.
NCT01806779 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01806779 about?
NCT01806779 is a clinical study titled "Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers". Previous results from the investigators' Center have shown that combination treatment with Chantix and Zyban is more successful in helping men quit smoking. The investigators hope to replicate these findings with this study.
What is the current status of trial NCT01806779?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 376 participants. The study started on 2013-03. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01806779?
The interventions under investigation include: Zyban (DRUG), Chantix (DRUG), Nicotine patches (DRUG).
Who is sponsoring clinical trial NCT01806779?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01806779's enrollment target sits among peer trials
376 116th of 2000 higher than 1,885 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03102125 · 376 participants · Phase 4
Allograft Dysfunction in Heart Transplant
- NCT05055297 · 376 participants · NA
SELUTION4BTK Trial
- NCT05912647 · 376 participants · NA
Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
- NCT05963971 · 376 participants · NA
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia